Skip to content Skip to sidebar Skip to footer

Newsletter

Nick Sundich

1,254 articles published

Healthcare Stocks

Here are 5 Monkeypox stocks to consider as the fight against the epidemic continues

Monkeypox stocks have enjoyed a good run in the last few weeks, with the World Health Organisation (WHO) classifying Monkeypox as a 'public health emergency of international concern'.Moneykpox is a virus that is spread through direct contact with infected liasons, bodily fluids or contaminated materials like bedding. It causes flu-like symptoms and skin blisters across…

ByNick SundichAugust 26, 20240Comments

Healthcare Stocks

Here are 6 important milestones of ASX biotech companies other than clinical trial results and regulatory approval

The list of major milestones of ASX biotech companies is headed with clinical trial results, regulatory approval and commercialisation. However, clinical trials can take a long time, and there are no guarantees of success. And, as goes without saying, there won't be regulatory approval or commercialisation without results.As important as they are, there are other…

ByNick SundichAugust 23, 20240Comments

Healthcare Stocks

Recce Pharmaceuticals investors are excited despite the market volatility – and there’s good reason

Recce Pharmaceuticals investors are amongst the few investors in ASX stocks that have a reason to smile right now. Their company has significantly outperformed the broader ASX, sitting in positive territory while the rest of the market has been volatile.Although there weren't any announcements out of Recce - other than the completion of its Share…

ByNick SundichAugust 22, 20240Comments

Consumer

Retail Food Group (ASX:RFG): The most underrated ASX fast food stock might be about to boost its profile

Retail Food Group (ASX:RFG) is flying under many investors' radars, and we think it is simply because its share price is below 10c. This company is actually worth nearly $200m, but its 2.5bn shares on issue makes it look like a penny stock to some investors. Nothing could be further from the truth.What has also…

ByNick SundichAugust 22, 20240Comments

Consumer

Here are 5 ASX stocks with fluctuating fortunes that have been firmly manifest this reporting season

Here are 5 ASX stocks with fluctuating fortunes (as observed this reporting season) Baby Bunting (ASX:BBN) Baby Bunting has a network of baby stores. You'd think a baby store company would be resilient to tough economic times because new parents can't put off all purchases for their newborns. But what new parents can do is…

ByNick SundichAugust 21, 20240Comments

Bank Stocks

Auswide and MyState are merging, will the Big 4 Banks be watching closely?

The biggest market news on August 19, 2024 was that Auswide and MyState are merging. The two small cap bank stocks, the former of which hails from Tasmania while the latter from the Queensland town of Bundaberg, may seem like an unlikely match at first glance, but the merger makes sense for both companies. Why Auswide…

ByNick SundichAugust 19, 20240Comments

Agriculture Stocks AI Stocks Airlines Bank Stocks Basic Materials Blue Chip Stocks Cannabis Stocks CleanTech Coal Stocks Cobalt Stocks Consumer Copper Stocks Cryptocurrencies Cybersecurity Stocks Defence Stocks Dividend Stocks Education Energy Stocks ETF Financials Gaming Stocks General Gold Stocks Graphite Stocks Healthcare Stocks Index Funds Industrials Iron Ore Stocks Large Caps Life Sciences Lithium Stocks Market news Mid Cap Stocks Mining Stocks News Nickel Stocks Oil and Gas Stocks Palladium Stocks Penny Stocks Property Real Estate Resources Retail Silver stocks Small Caps Stocks Tech Stocks Technology Telecommunications Stocks Travel Stocks Uncategorized Undervalued Stocks Uranium Stocks Vanadium Stocks

Here are 4 economic indicators that impact stocks and investors must pay attention to

There are several economic indicators that impact stocks, both on the ASX and internationally. Whenever data is released, it can swing market indices in a particular direction, sometimes the opposite direction to where it had been heading earlier in the day. This is not only if the data changes from one period to another, but…

ByNick SundichAugust 19, 20240Comments

Bank Stocks Basic Materials Blue Chip Stocks Cannabis Stocks Consumer Defence Stocks Education Energy Stocks General Index Funds Industrials Large Caps Market news Mining Stocks News Real Estate Resources Tech Stocks Technology Travel Stocks

6 of the best performing ASX All Ords stocks in the past year

6 of the best performing ASX All Ords stocks in the past year Clarity Pharmaceuticals (ASX:CU6) Clarity is a late-stage clinical biotech, testing its Targeted Copper Theranostics (TCT) technology in a pivotal clinical trial. TCT is a radiation-based therapy that delivers treatment directly to the cells rather than the outside. This is the type of…

ByNick SundichAugust 16, 20240Comments

Agriculture Stocks AI Stocks Bank Stocks Blue Chip Stocks Consumer Education Energy Stocks ETF Financials Gaming Stocks General Healthcare Stocks Index Funds Large Caps Life Sciences Market news Mid Cap Stocks Mining Stocks News Penny Stocks Property Real Estate Resources Retail Small Caps Stocks Tech Stocks Technology Telecommunications Stocks Travel Stocks Uncategorized Undervalued Stocks

As lower interest rates loom, here are 6 ASX stocks that will benefit from forthcoming rate cuts

Here 6 ASX stocks that will benefit from lower interest rates! AGL Energy (ASX:AGL) You might think AGL is on this list because people will have an easier time paying their electricity bills. Not quite for two reasons: First, Blind Freddy could tell you that, and Second, people are still paying their bills. We were…

ByNick SundichAugust 14, 20240Comments

Healthcare Stocks Mid Cap Stocks

Curvebeam AI (ASX:CVB): Could this company be the next Pro Medicus?

Not many ASX medtech companies can boast of a then US President elect as a patient, but Curvebeam AI (ASX:CVB) is one of them. And there's good reason too - because its technology can detect injuries and fracture risk where its peers cannot. CurveBeam AI and the secret sauce behind its technology CurveBeam AI develops and…

ByNick SundichAugust 13, 20240Comments

the Kick-ass Multipurpose WordPress Theme

Nick Sundich

Here are 5 Monkeypox stocks to consider as the fight against the epidemic continues

Here are 6 important milestones of ASX biotech companies other than clinical trial results and regulatory approval

Recce Pharmaceuticals investors are excited despite the market volatility – and there’s good reason

Retail Food Group (ASX:RFG): The most underrated ASX fast food stock might be about to boost its profile

Here are 5 ASX stocks with fluctuating fortunes that have been firmly manifest this reporting season

Auswide and MyState are merging, will the Big 4 Banks be watching closely?

Here are 4 economic indicators that impact stocks and investors must pay attention to

6 of the best performing ASX All Ords stocks in the past year

As lower interest rates loom, here are 6 ASX stocks that will benefit from forthcoming rate cuts

Curvebeam AI (ASX:CVB): Could this company be the next Pro Medicus?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Nick Sundich

Stocks in Spotlight

Add Your Heading Text Here